Explore every episode of the podcast The Orange Pill Podcast

The supplement aisle is changing-fast.

In Episode 105, we break down the five biggest shifts redefining wellness by Fall 2026, from personalized nutrition and postbiotics to nootropics, longevity science, and the rise of women’s health as a market powerhouse.

This isn’t about taking more supplements- it’s about taking the right ones, in smarter, more effective ways.

If you want to stay ahead of where the industry (and your health routine) is going, this episode is your roadmap.

Peptides are exploding in popularity-but the rules around them are anything but clear.

In Episode 104, we unpack the growing clash between RFK Jr. and the FDA over peptide regulation, the rise of the gray market, and what this means for safety, access, and the future of clinical innovation.

This isn’t just a policy debate-it’s a turning point for the entire wellness industry.

Vitamin D has long been associated with bone health-but emerging neuroscience suggests its role goes far beyond that.

In this episode, we explore how the so-called “sunshine vitamin” may influence brain structure, cognitive function, and long-term mental health outcomes.

From its role as a neurosteroid regulating hundreds of genes to its connection with depression, ADHD, and dementia risk, the data is beginning to paint a much bigger picture.

We also unpack: ✔ Why midlife Vitamin D levels may impact brain health decades later ✔ The link between geography, sunlight exposure, and mental health risk ✔ The surprising reality of widespread deficiency-even in sunny regions

As research continues to evolve, one question becomes hard to ignore:

Are we underestimating the role of Vitamin D in shaping brain health across the lifespan?

Anxiety is often framed as a psychological condition- but what if part of the story is biological?

Emerging research in nutritional psychiatry is uncovering a consistent metabolic signature in individuals with anxiety: reduced levels of choline in the brain.

In this episode, we explore the science behind this discovery, including: ✔ An 8% reduction in brain choline linked to anxiety ✔ The role of choline in brain structure, signaling, and resilience ✔ Why chronic stress may be depleting key nutrients ✔ What this means for future clinical and nutritional strategies

As the line between mental health and metabolism continues to blur, this episode asks a critical question:

Are we overlooking a fundamental nutritional gap in how we approach anxiety?

For decades, cardiovascular care has focused on slowing disease and not reversing it. But new clinical data is challenging that paradigm.

In this episode, we break down emerging evidence showing that high-dose Nattokinase, a fibrinolytic enzyme derived from fermented soy, may do more than support heart health. It may actively reduce arterial plaque.

From a 36% reduction in carotid plaque size to insights into autophagy, inflammation, and the gut-heart axis, this episode explores what these findings really mean and where the science still needs scrutiny.

If you’re working in cardiovascular health, nutraceutical innovation, or clinical research, this is one conversation you don’t want to miss.

100 episodes in and we’re tackling one of the most critical shifts in the industry.

In Episode 100 of the Orange Pill Podcast, we break down recent FDA enforcement actions from CDER’s BIMO program that reveal a hard truth:

Your supplement can become a drug- based on how you study it.

From enrolling diseased populations without an IND to unethical consent practices and compromised data integrity, these cases highlight the increasing scrutiny on clinical trials in the wellness space.

If you’re running or planning a study, this episode isn’t optional listening.

What if the safety data behind a drug… couldn’t be verified?

In Episode 99 of the Orange Pill Podcast, we break down a recent FDA Warning Letter that exposed a troubling “liaison” model, where a contract research company claimed ownership of studies it never actually conducted.

From falsified study directors to missing raw data, this case reveals how gaps in oversight can compromise the very foundation of drug development, and why sponsors can no longer rely on paper compliance alone.

You trust that every ingredient in your food has been reviewed for safety.

But what if no one is actually checking?

In Episode 98 of the Orange Pill Podcast, we unpack the GRAS loophole- a decades-old regulatory pathway that allows companies to self-affirm the safety of food ingredients, often without notifying the FDA.

From legacy additives like BHA to the growing concern around endocrine-disrupting chemicals, this episode explores the transparency crisis shaping today’s food supply, and what “radical transparency” could mean for the future.

By 2050, the world will need to feed 10 billion people.

Traditional food innovation simply isn’t fast enough.

In Episode 97 of the Orange Pill Podcast, we explore how Artificial Intelligence is transforming the way food is discovered, designed, and delivered- from identifying hidden health compounds in plants to predicting taste, texture, and nutrition before a product even reaches the lab.

From precision nutrition to AI-driven ingredient discovery, the future of food may be built not just by farmers and chefs, but by algorithms.

For years, multivitamins have lived in a scientific gray zone- praised by some, dismissed by others.

Now one of the largest supplement trials ever conducted may finally shift the conversation.

In Episode 96 of the Orange Pill Podcast, we break down the results of the 21,000+ participant COSMOS trial, revealing how daily multivitamins may slow biological aging and how cocoa flavanols could reduce cardiovascular death risk by 27%.

The takeaway? Your morning supplement routine might actually be doing more than you think.

Your supplements may no longer come from farms-  they might come from labs.

In Episode 95 of the Orange Pill Podcast, we break down the FDA’s upcoming town hall examining whether ingredients produced through precision fermentation, cell culture, and recombinant biotechnology still qualify as “dietary ingredients” under the 1994 DSHEA law.

At the center of the debate: Section 201(ff)(1)(E),  a single line of legislation that could determine the future of probiotics, enzymes, proteins, and next-generation bioengineered nutrients.

Because when science evolves faster than regulation, the definition of a supplement may need a rewrite.

What if your supplement is legal in one state… but restricted the moment you cross a bridge?

In Episode 94, we break down the 2026 legislative shift reshaping the supplement industry - from New York’s age restrictions to the federal Uniformity Act and the looming hemp “THC cliff” in the Farm Bill.

The era of 50 different rulebooks may be ending.

Or it may just be getting started.

2026 isn’t business as usual.

It’s a legislative wildfire.

From dye bans and heavy metal mandates to accidental labeling laws and GRAS reform, state legislatures are rewriting food and supplement policy at breakneck speed.

In Episode 93 of the Orange Pill Podcast, we break down the surge of state-level bills that could fracture the national market,  and why manufacturers may soon face 50 different rulebooks.

Because in 2026, your supplement isn’t just a product.

It’s a political battleground.

80% of seafood. Over half of fresh fruit. Thousands of supplements.

That’s how much of the American diet is produced overseas.

So what happens when FDA foreign inspections hit historic lows?

In Episode 92 of the Orange Pill Podcast, we unpack the sharp decline in international food and supplement facility inspections, the administrative breakdown behind it, and what it means for public health, regulatory strategy, and global supply chain accountability.

Because when oversight shrinks, risk expands.

For over 2,000 years, turmeric has been revered as a healing powerhouse, from ancient Ayurveda to today’s booming $155M+ curcumin supplement market. With more than 11,000 scientific publications supporting its anti-inflammatory and antioxidant benefits, it’s long been considered one of the safest “superfoods” on the planet.

So why are global regulators suddenly issuing liver safety warnings?

In Episode 91 of the Orange Pill Podcast, we unpack the emerging controversy around turmeric-induced hepatotoxicity and explore the real issue: not the spice itself, but how modern bioavailability “hacks” may be overwhelming the body’s natural safety systems.

Inside this episode:

• Why curcumin’s naturally low absorption was actually a built-in evolutionary safeguard

• How piperine can increase bioavailability by 2,000%  and what that means for liver metabolism

• Why Health Canada, Australia’s TGA, and European regulators are mandating warning labels

• The rare but serious liver injury cases linked to high-potency supplements

• The “genetic gamble” behind idiosyncratic liver reactions

• Why your curry is likely safe, but your capsule might not be

This episode isn’t anti-turmeric. It’s a deeper conversation about potency, delivery systems, and what happens when we outsmart the body’s natural defenses.

Because in the pursuit of wellness, sometimes more isn’t better - it’s riskier.

Ultra-processed foods now make up over half of the average adult’s calories and nearly 60% of children’s diets.

They look harmless. They’re marketed as “natural.” Some even carry health halos.

But behind the packaging lies a system built on loopholes, engineered starches, and thousands of additives the FDA may never have formally reviewed.

In Episode 90 of the Orange Pill Podcast, we unpack the growing bipartisan alarm around ultraprocessed foods - from the controversial GRAS loophole to the striking alliance between Robert F. Kennedy Jr. and former FDA Commissioner Dr. David Kessler under the “Make America Healthy Again” banner.

This isn’t about fear. It’s about understanding how policy, processing, and profit reshaped the modern pantry.

Because the real question isn’t just what are we eating? It’s who decided it was safe in the first place?

High heat built the modern food system. But it may also be limiting it.

In Episode 89, we explore how Novel Food Processing (NFP) technologies are transforming protein at the molecular level, unlocking better texture, higher bioavailability, improved digestibility, and cleaner labels without sacrificing safety.

From electricity-powered milk processing to ultra-high pressure seafood engineering, this episode breaks down how food science is moving beyond the burner and into the future.

If you work in food innovation, functional ingredients, protein R&D, or regulatory strategy, this one changes how you think about what’s possible.

What if many of the ingredients in your food were never reviewed by the FDA?

In Episode 88 of the Orange Pill Podcast, we break down the newly introduced GRAS Oversight and Transparency Act (February 3, 2026); a bill that aims to close one of the most controversial loopholes in U.S. food regulation.

For decades, the “Generally Recognized as Safe” (GRAS) framework has allowed companies to self-determine ingredient safety without notifying the FDA, leaving regulators and consumers in the dark. This episode unpacks how that system works, why it matters, and how this new legislation could permanently reshape food ingredient oversight.

From legacy ingredients approved decades ago, to a new interagency GRAS Review Board with real enforcement authority, we explore what this bill means for manufacturers, regulators, and the future of food transparency.

Erythritol has earned a near-perfect reputation in the clean-eating world. It’s natural, calorie-free, keto-friendly, and widely considered one of the safest sugar substitutes on the market.

But new research from the University of Colorado suggests that this confidence may be dangerously misplaced.

In Episode 87 of the Orange Pill Podcast, we unpack a startling new study from the DeSouza laboratory that shows how erythritol may quietly compromise the blood-brain barrier (BBB), the brain’s most critical line of defense against toxins, inflammation, and vascular injury.

This episode breaks down:

• How erythritol triggers a 75% surge in oxidative stress inside brain endothelial cells • Why the body’s antioxidant defenses can’t keep up • How nitric oxide suppression and endothelin-1 elevation promote dangerous vessel constriction • Why erythritol may disable the brain’s natural “clot-buster” response • And most critically, why these effects occur at blood concentrations reached after a single serving

This isn’t a story about extreme overconsumption. It’s about everyday exposure hiding behind a “natural” label.

If you consume sugar-free snacks, energy drinks, or keto products, this episode is essential listening.

Many wellness and nutraceutical companies believe that calling a product a dietary supplement creates a regulatory safe zone. FDA enforcement actions tell a very different story.

In Episode 86 of the Orange Pill Podcast, we break down the FDA’s Bioresearch Monitoring (BIMO) Program and analyze recent FDA Warning Letters that caught sponsors, CROs, and IRBs completely off guard.

This episode explains a hard regulatory truth: the FDA does not regulate labels - it regulates intent.

We explore three critical lessons drawn directly from enforcement actions involving U.S.-based clinical trials:

• Why study design, not product category, determines whether something is legally a drug • How enrolling diseased subjects instantly converts a “supplement study” into a drug trial • Why skipping an IND isn’t a paperwork error but a serious safety and data integrity failure • How validated clinical instruments can unintentionally trigger drug classification • The role CROs and IRBs play and where accountability ultimately falls

If your clinical trial measures disease outcomes, targets pathology, or recruits diagnosed populations, the FDA will treat it as a drug study, regardless of what’s on the bottle.

This episode is essential listening for sponsors, CROs, regulatory teams, and anyone designing human research in the supplement space.

For years, protein dominated the wellness conversation. Shakes, bars, and macro tracking became the gold standard of “healthy.” But a new movement is rapidly reshaping nutrition culture  and it isn’t coming from gyms or supplement brands. It’s coming from the gut.

In Episode 85 of the Orange Pill Podcast, we unpack the science behind #Fibermaxxing - the viral trend shifting attention from protein obsession to microbiome-driven health.

This episode explores why fiber has suddenly become the internet’s most powerful nutrient and how it connects directly to the decade’s most talked-about pharmaceutical target: GLP-1.

We break down:

• How fiber naturally stimulates GLP-1 -  the hormone behind fullness, glucose control, and metabolic regulation • Why the U.S. is facing a hidden fiber deficiency crisis • The biological risks of jumping from low fiber to extreme fiber overnight • The overlooked science of soluble vs. insoluble fiber and fermentation • How ultra-processed “fiber-added” foods differ from whole-food fiber sources • And a practical, microbiome-safe way to increase intake without digestive fallout

Fibermaxxing isn’t a hack. It’s a return to biological fundamentals.

For decades, America’s food system operated in a gray zone where chemicals could quietly enter the supply chain, nutrition guidance lagged behind chronic disease, and safety was often reactive rather than preventive.

That era is ending.

In Episode 84 of the Orange Pill Podcast, we unpack the FDA’s newly solidified Human Foods Program (HFP) and its sweeping 2026 agenda, a regulatory blueprint that signals one of the most aggressive transformations in food policy in modern history.

This episode explores how the FDA is shifting from a watchdog to an architect of national health, built around three core pillars: Food Chemical Safety, Nutrition, and Microbiological Food Safety.

We dive into what’s actually coming in 2026, including:

• The dismantling of the GRAS loophole and the rise of mandatory pre-market chemical transparency • The targeted review of controversial additives like phthalates, BHA, BHT, and parabens • The phase-out of petroleum-based food dyes in favor of plant-derived colors • New front-of-package nutrition labeling designed to influence real-time consumer behavior • FDA’s expansion into microplastics, heavy metals, and PFAS oversight • The modernization of infant formula standards under Operation Stork Speed • And the federal effort to formally define “ultra-processed foods”

This is not incremental regulation. It is a structural reset of the relationship between government, industry, and the grocery shelf.

For nearly a century, U.S. cosmetic regulation remained largely unchanged. That era officially ended with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), and now, the FDA is racing to catch up.

In Episode 83 of the Orange Pill Podcast, we unpack five major regulatory developments that signal a fundamental shift in how cosmetics are tested, labeled, and enforced in the United States.

Drawing from recent FDA actions and the Fall 2024 Unified Agenda, this episode explores:

• The FDA’s long-awaited move to mandate asbestos testing in talc products • Why the agency is using a broader mineral definition to future-proof safety • How fragrance “trade secrets” are ending with allergen disclosure rules • The delayed but historic push toward a formaldehyde ban in hair products • How the 2025 administrative transition has triggered a widespread regulatory freeze impacting MoCRA timelines

We discuss what these shifts mean for brands, manufacturers, regulatory teams, and consumers, and why companies should already be preparing their quality systems, documentation, and compliance strategies.

This episode isn’t just about beauty. It’s about accountability, transparency, and the future of consumer protection.

The world is facing a neurological emergency. Dementia cases are projected to nearly triple by 2050, and despite decades of pharmaceutical research, effective, scalable solutions remain limited. This has pushed scientists to look beyond single-target drugs and toward food-based, systems-level interventions.

In Episode 82 of the Orange Pill Podcast, we explore why red beetroot is emerging as a serious scientific contender in the fight against what many researchers now call “Type 3 Diabetes” , the metabolic and insulin-resistant decline of the aging brain.

This episode unpacks groundbreaking research showing that beetroot’s benefits are not just nutritional, but neurological, vascular, and microbiome-dependent.

It also reframes brain health as a mouth-to-microbe-to-mitochondria conversation, and positions beetroot as a powerful example of how whole foods may influence neurodegeneration.

🎧 Listen to Episode 82 to discover why the future of cognitive resilience may begin not in the pharmacy, but in the produce aisle.

Colostrum, often called “liquid gold”, has taken over longevity circles, biohacking podcasts, and premium supplement shelves. Marketed for everything from gut health to immune resilience and anti-aging, its popularity has surged faster than human clinical research.

In Episode 81 of the Orange Pill Podcast, we break down a newly published randomized, double-blind, placebo-controlled clinical trial from the Journal of Functional Foods that finally puts colostrum to the test in adults aged 55–70.

This episode explores what the data actually shows:

• Colostrum’s antibodies survive digestion and remain bioactive in the gut • IGF-1 levels increased while age-related decline continued in the placebo group • Participants saw reduced leg fat accumulation, suggesting metabolic preservation • Markers pointed toward immune priming, not just passive immunity • No short-term changes in bone density or cognition - a reality check on timelines • A strong safety profile, with mostly mild, short-term digestive effects

Rather than a miracle cure, this study positions colostrum as a biologically active, patience-requiring intervention for immune and metabolic resilience in aging populations.

Neuropathic pain affects up to 18% of the global population and remains one of the most difficult chronic conditions to manage. Existing therapies often come with serious trade-offs such as sedation, dependency, and limited long-term relief, highlighting the urgent need for safer, more effective solutions.

In Episode 80 of the Orange Pill Podcast, we explore fascinating new preclinical research on geraniin, a naturally occurring compound found in plants like the peel of the rambutan fruit. The study suggests this compound doesn’t just blunt pain signals, it may actually help damaged nerves function better.

Rather than acting as a single-target “painkiller,” geraniin demonstrated a multi-pathway approach, addressing several biological drivers of nerve damage at once.

This research highlights the growing potential of complex natural compounds in tackling equally complex chronic conditions.

When you scan a food or supplement label, you might assume you’re seeing the most credible health information available. But what if some of the most authoritative, government-backed science is being kept off labels altogether?

In this episode of the Orange Pill Podcast, we unpack a new legal battle that’s putting the FDA’s regulatory authority, free speech, and consumer rights under the spotlight. At the center of the case is a surprising contradiction: claims drawn directly from research published by the NIH, CDC, and other federal health agencies are being blocked by the FDA from appearing on product labels.

We explore: • Why the FDA is preventing companies from sharing government-authored health findings • How a 1997 law was designed to allow these claims and why critics say the FDA overrode Congress • Why this case is being framed as a First Amendment issue, not just a regulatory one • How a recent Supreme Court ruling could dramatically shift the balance of power • What this fight means for scientific transparency and informed consumer choice

This episode isn’t just about supplements. It’s about who gets to decide what health information reaches the public and whether consumers are being protected or restricted.

More than one in four adults struggle to fall or stay asleep and while prescription sleep aids can help, they often come with side effects like grogginess, confusion, and memory impairment. That’s why researchers are increasingly searching for safer, evidence-based alternatives.

In this episode of the Orange Pill Podcast, we dive into a fascinating new triple-blind, placebo-controlled clinical trial published in Food Science & Nutrition that explored a standardized Corn Leaf Extract (CLE) as a natural sleep aid.

The results were striking.

We also explore one of the most intriguing findings of all: while objective brain data showed clear improvements over placebo, both groups felt their sleep had improved - highlighting the powerful difference between perception and measurable physiology.

This episode unpacks what this means for the future of natural sleep solutions and why objective clinical tools matter more than ever.

As dementia rates climb worldwide, projected to reach nearly 153 million cases by 2050, diet has emerged as one of the most important modifiable risk factors. But the science behind “brain food” is far more complex than simply avoiding certain foods or adding others.

In this final episode of the year, the Orange Pill Podcast takes a deep dive into three surprising scientific findings that are reshaping how we think about diet and long-term cognitive health.

In Episode 77, we explore: • Why the inflammatory potential of your overall diet matters more than individual foods • How a massive 25-year study found high-fat cheese and cream were associated with lower dementia risk • Why “healthy eating” isn’t one-size-fits-all  and how race, genetics, and vascular health change outcomes

Drawing from large population studies including the Framingham Heart Study, Malmö Diet and Cancer cohort, and the Chicago Health and Aging Project, this episode challenges simplistic narratives and points toward a more personalized, inflammation-aware approach to brain health.

As we wrap up the year, this episode invites a more thoughtful question: What does a truly brain-healthy diet look like for you?

Dietary supplements promise strength, focus, resilience, and disease prevention, but how well do we truly understand their benefits and risks?

In Episode 76 of the Orange Pill Podcast, we take a deep dive into one of the most comprehensive investigations of supplement use ever conducted: a Department of Defense–commissioned report by the Institute of Medicine examining dietary supplement use among U.S. military personnel- one of the world’s most physically and mentally stressed populations.

This episode unpacks the most important and surprising findings, including:

• Why supplements are regulated as foods, not drugs, and what that really means for safety • Why “sold on base” does not mean “military-approved” • The proven benefits and real limitations of caffeine as a performance aid • The striking gap between supplement use and disclosure to healthcare providers • Why more clinical research is urgently needed in high-stress populations like the military

We also address common misconceptions about FDA oversight, dietary supplement GMPs, and adverse event reporting, revealing a regulatory framework that is often misunderstood by the public.

This episode offers critical insights not just for service members, but for consumers, healthcare providers, regulators, and supplement brands alike.

Weight-loss science is having a renaissance. While today’s blockbuster drugs curb appetite by acting on the brain, a groundbreaking new discovery points to an entirely different frontier - one inside the gut.

In Episode 75 of the Orange Pill Podcast, we explore a remarkable molecule produced not by our bodies, but by our gut bacteria. It’s called Desaminotyrosine (DAT), and new research suggests it could help the body burn fat faster, cleaner, and without ever decreasing appetite.

This discovery points toward a future where weight management isn't about eating less,  but about helping your gut bacteria work smarter.

Listen to Episode 75 to learn how your microbiome could become one of the most powerful tools in metabolic health.

In a world where stress is constant and focus feels fleeting, many people turn to L-theanine, the calming amino acid found in green tea. But new clinical research on a purified form, AlphaWave® L-Theanine, reveals a story far more sophisticated than the usual “relaxation without drowsiness” claim.

In Episode 74 of the Orange Pill Podcast, we unpack four surprising scientific discoveries that challenge long-held assumptions about L-theanine and how it affects the brain:

1️⃣ It creates a measurable state of “relaxed wakefulness.” A single dose significantly boosts alpha brainwaves - the same patterns seen in meditation.

2️⃣ It sharpens attention, not just calm. In a 28-day clinical trial, participants taking AlphaWave® improved their cognitive reaction speed faster and more consistently than placebo.

3️⃣ It may improve sleep efficiency, not sleep duration. Surprisingly, participants slept less but maintained strong next-day cognitive performance - suggesting more restorative sleep cycles.

4️⃣ Your mindset matters too. The study also showed that placebo participants reported lower stress, highlighting the powerful interplay between biology and belief.

This episode paints a new picture of L-theanine as a cognitive state modulator, not just a calming agent - one that helps the brain filter out stress “noise” while elevating focus, clarity, and restorative rest.

🎧 Tune in to Episode 74 to explore the science behind stress, focus, and the future of nootropics.

The global protein crisis is here and science may have just delivered an unexpected solution: a gene-edited fungus that uses 44% less sugar, grows 88% faster, produces clean, complete protein, and still tastes remarkably like meat.

In this episode of the Orange Pill Podcast, we dive into groundbreaking new research on Fusarium venenatum, the same fungus behind mycoprotein, and explore how a precise, “scarless” CRISPR edit is reshaping the sustainability, nutrition, and future potential of alternative proteins.

From environmental impact to regulatory acceptance to consumer perception, this episode explores how fungi, and gene-edited foods more broadly, may redefine the future of protein on a warming planet.

The supplement aisle is packed with promises - better sleep, stronger immunity, improved focus - but how much of it is truly backed by science?

In this episode of the Orange Pill Podcast, we go beyond the marketing noise to explore five surprising truths decades of research have revealed about dietary supplements. From the downfall of once-hyped herbal remedies to the rise of personalized nutrition and the untapped influence of the gut microbiome, this episode challenges the outdated “one nutrient, one solution” mindset.

We uncover: • Why some of the biggest studies on popular herbs failed • Why “one-size-fits-all” nutrition simply doesn’t work • How your gut microbes change how supplements behave • The real story behind industry-funded research • How nutrition science has evolved from deficiency prevention to health optimization

This is a must-listen for anyone who wants to make smarter, science-driven choices about their health and understand what’s truly shaping the future of supplements.

Most of us trust that the foods we buy are safe and clearly labeled,  but a new bill in Washington may quietly change the rules.

In this episode, we break down the “Better Food Disclosure Act of 2025”, a bill introduced by Senator Roger Marshall that promises to strengthen transparency in the food system. At first glance, it looks like progress. But beneath the surface are four major structural issues that critics warn could actually weaken food safety regulation, not strengthen it.

We explore: • How new food chemicals could be approved by default if the FDA runs out of time • Why removing unsafe ingredients may become harder than ever • The massive, unfunded workload the bill hands to an already overextended FDA • How “disclosure” doesn’t necessarily mean public transparency

With insights from the Center for Science in the Public Interest (CSPI), we uncover why some experts are calling this bill a legislative “lobster trap”- easy for chemicals to enter the food supply, nearly impossible to remove them once inside.

Join us for Episode 71 as we unpack the fine print and help you understand what this bill could mean for public health and the future of food safety in the U.S.

That “Clinically Proven” label on your favorite supplement might not mean what you think. In this episode, we peel back the curtain on the world of health product research, where not all studies are created equal.

Join us as we explore five surprising truths about how health products are tested, from the misuse of patient-reported outcomes (PROs) to the hidden pitfalls of fully virtual trials. You’ll learn why the FDA is cracking down on vague “quality of life” claims, how some trials rely on predicted margins instead of actual data, and why the future of clinical research lies in hybrid trial design, combining scientific rigor with participant convenience.

If you’re a supplement brand, formulator, or regulatory professional, this is an episode you don’t want to miss.

The U.S. dietary supplement industry is thriving, but beneath the surface of growth lies a rising wave of class action litigation that’s reshaping how brands think about packaging, marketing, and labeling.

In this episode of the Orange Pill Podcast, we uncover three emerging legal trends every supplement company should know:

1️⃣ Slack-fill lawsuits - why “empty space” in your packaging could cost millions. 2️⃣ Protein spiking claims - the controversy shaking up the protein powder market. 3️⃣ “Made in the USA” pitfalls - how global sourcing could land domestic brands in legal hot water.

Compliance with FDA rules is no longer enough. Learn how to protect your brand reputation and stay ahead of these new legal risks reshaping the supplement industry.

The legalization of cannabis has created a billion-dollar problem that technology is only now catching up to solve: how can we accurately measure impairment, not just use?

In this episode of the Orange Pill Podcast, we dive into groundbreaking research featuring the Cognalyzer®- a novel EEG-based device that measures brainwave alterations to detect cannabis impairment directly. Unlike traditional methods such as saliva or blood tests, which can penalize sober individuals long after consumption, this technology focuses on what truly matters: the brain’s current state.

This episode challenges assumptions, highlights the science, and explores how objective data can pave the way for smarter regulation and safer consumption.

Aggression, from playground fights to serious violence,  has long challenged families and communities alike. But what if one of the simplest, safest, and most effective tools for reducing aggression has been sitting on our dinner plates all along?

In this episode, we explore a groundbreaking new meta-analysis spanning nearly 30 years of research that reveals how omega-3 supplementation, the same fatty acids found in fish oil, can reduce aggression by up to 30%.

Join us as we unpack:

• The evidence behind 29 randomized controlled trials

• How omega-3 helps regulate both “hot” and “cold” aggression

• Why experts are calling for its immediate implementation

• And how this simple nutritional step could transform mental health strategies

Tune in to discover how a small dietary change could make a big difference in behavior, brain health, and community well-being.

We all try to eat better,  loading up on antioxidant-rich berries, turmeric, and green veggies,  but here’s the surprising truth: many of those “super-nutrients” never make it past your digestive system.

In this episode of the Orange Pill Podcast, we explore how nanotechnology is rewriting the rules of nutrition. From nanoencapsulation that protects fragile compounds like curcumin and quercetin, to upcycling food waste into potent new supplements, science is finally addressing the “bioavailability bottleneck.”

But with every breakthrough comes new questions, about safety, regulation, and the fine line between innovation and over-engineering our food. Are we entering an era of “programmed nutrition,” and what will it mean for the future of health and wellness?

Fermented foods like cheese, wine, and cured meats are celebrated for their complex flavors, but they may harbor hidden risks. In this episode of The Orange Pill Podcast, we explore the world of biogenic amines (BAs), naturally occurring compounds that can pose health hazards despite their delicious origins. From the “cheese effect” of tyramine to toxic synergy among multiple amines, we discuss why regulating histamine alone isn’t enough. Learn why food safety experts are calling for clear specifications for biogenic amines in foods and dietary supplements, and how manufacturers can proactively protect consumers.

In Episode 64, we continue to unpack the regulatory evolution of cannabis and cannabidiol (CBD) in Canada (continuation of Episode 44) and what’s next for the industry. From the Cannabis Act to proposed pathways that could finally allow CBD Natural Health Products (NHPs) to be sold without prescriptions, this episode dives deep into how Health Canada’s changing stance could reshape accessibility, innovation, and economic opportunity. 

For most Americans, a government shutdown means furloughs, temporary disruptions that end when funding returns. But October 2025 marks a turning point. The Trump administration’s move to issue Reductions in Force (RIFs) across key agencies like HHS, FDA, and the CDC has transformed a short-term budget standoff into a permanent restructuring of the federal workforce.

In this episode, we break down:

• The difference between a furlough and a RIF, and why it matters now more than ever.

• The scale of workforce reductions and their ripple effects on public health and food safety.

• The political and economic motivations behind using the shutdown as a tool to shrink government size.

• Historical parallels to past administrations and what they reveal about the long-term agenda.

Tune in to explore how this unprecedented move could reshape America’s public health infrastructure, and redefine the meaning of “non-essential.”

After nearly three years of uncertainty, the FDA has officially reversed its stance on Nicotinamide Mononucleotide (NMN), the popular anti-aging compound once banned from supplement shelves.

In this episode, we unpack the twists and turns that led to the agency’s dramatic U-turn, the key legal reinterpretation that changed everything, and how relentless industry advocacy forced the FDA’s hand.

From Citizen Petitions to regulatory chaos, discover what really happened behind the scenes, and why this win for NMN could foreshadow the next big battle in dietary supplement regulation.

Tune in to understand the future of NMN, the gaps still left unaddressed, and what this means for innovation in the supplement industry.

Most diets promise weight loss but leave you battling hunger, losing precious muscle, and facing rebound weight gain. But what if there’s another way?

In this episode of the Orange Pill Podcast, we break down a recent clinical trial published in Clinical Nutrition Open Science that tested the Bone Broth Diet (BBD), a mix of intermittent fasting, high-protein/low-carb meals, and collagen-rich bone broth.

The results? Surprisingly powerful:

✅ Fat loss with muscle preservation

✅ Reduced hunger and cravings without sacrificing satisfaction

✅ Improved blood sugar, triglycerides, and waist circumference

✅ Built-in flexibility for long-term success

This isn’t just another diet trend — it’s a new perspective on sustainable weight management.

From sourdough bread to kombucha, fermentation has long been a cornerstone of human diets. But what was once a preservation method is now driving some of the boldest innovations in food science. In this episode, we explore five surprising ways fermentation is transforming the future of food—from unlocking hidden nutrition and reintroducing microbial diversity, to turning food waste into gourmet ingredients, breeding microbes for flavor, and even creating animal products without the animal.

Fermentation has evolved from an ancient art into a modern marvel, one that promises healthier, more sustainable, and more exciting food for the future.

From farm to fork, our food supply chain is one of the most complex in the modern world. But while we often imagine technology’s role as simply faster machines or warehouse robots, the true disruption is happening in ways we don’t see.

In Episode 59 of the Orange Pill Podcast, we uncover four surprising ways AI and IoT are secretly reshaping the food industry—from collapsing product development timelines and predicting real consumer trends, to making food safety proactive and even delivering unexpected green dividends in logistics.

You’ll hear how these “invisible” systems are bringing clarity, foresight, and accountability to the food we eat, and why the biggest changes are still just over the horizon.

Caffeine is the world’s most widely consumed psychoactive substance, naturally found in coffee, tea, and chocolate, but now added to everything from energy drinks and supplements to waffles and chewing gum. With this rapid expansion, regulators and health experts are re-examining the science and safety of caffeine consumption.

In this episode, we break down:

• Safe daily intake levels for healthy adults and vulnerable groups.

• The unique risks for children, adolescents, and pregnant women.

• How genetics can influence caffeine sensitivity and cardiovascular risk.

• Emerging concerns with energy drinks, substance interactions, and long-term effects.

• Where the science is strong—and where the biggest data gaps remain.

Coffee and caffeine are cultural cornerstones in the United States, but consumption trends have shifted dramatically over the past century. From the wartime rise of instant coffee to today’s specialty café culture and booming energy drink market, Americans’ relationship with caffeine keeps evolving.

In this episode of the Orange Pill Podcast, we unpack key findings from recent research on coffee and caffeine consumption patterns in the U.S.

Tune in as we break down the data, the history, and the health implications of America’s caffeine habits.

In this episode of the Orange Pill Podcast, we explore the promise of D-mannose, a functional sugar gaining recognition as a non-antibiotic solution for urinary tract infections (UTIs).

We break down findings from a randomized, triple-blind, placebo-controlled study (Current Urology, 2025) where the product UClear, developed by KEB Nutraceuticals and clinically tested by KGK Science, demonstrated significant improvements in UTI symptoms after just 3 days of supplementation.

Join us as we unpack the science, the clinical trial data, and the broader implications for women’s health and nutraceutical innovation.